Interpace Biosciences (IDXG) Earnings Date & Reports

Interpace Biosciences Inc provides esoteric molecular diagnostic testing and pathology services to aid physicians in evaluating cancer risk in patients with indeterminate biopsies and a perceived high risk of cancer based on clinical features... Show more

Industry: #Servicestothe Health Industry

Get AI intraday signals

A.I. Advisor

published Earnings

IDXG is expected to report earnings to fall 191.67% to 10 cents per share on March 07

Interpace Biosciences IDXG Stock Earnings Reports

Q4'23

Est.

$0.11

Q3'23

Missed

by $0.11

Q2'23

Beat

by $0.17

Q1'23

Beat

by $0.29

Q4'22

Missed

by $0.26

The last earnings report on November 08 showed earnings per share of -11 cents, missing the estimate of 0 cents. With 7.52K shares outstanding, the current market capitalization sits at 8.62M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a provider of commercialization services to biopharmaceutical companies

Industry MedicalSpecialties

Profile

Fundamentals

Details

Industry

Servicestothe Health Industry

Address

300 Interpace Parkway

Phone

+1 855 776-6419

Employees

Web

https://www.interpace.com